Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Combined With Conventional Therapy in Fibromyalgia
NCT07230171Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of esketamine in fibromyalgia (FM) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change from baseline in the mean pain intensity at 1 week. Started Sep 2025; status: completed.
02
Drugs
esketamine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07230171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230171.